Mesothelioma Clinical Trials in Boston, Massachusetts
7 recruitingBoston, Massachusetts
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 1Phase 2
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
NSCLCSolid Tumor, AdultMesothelioma
Vivace Therapeutics, Inc434 enrolled12 locationsNCT04665206
Recruiting
Not Applicable
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Mesothelioma
Dana-Farber Cancer Institute240 enrolled1 locationNCT03683680
Recruiting
Phase 2
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Mesothelioma
Brigham and Women's Hospital130 enrolled1 locationNCT05730816
Recruiting
Not Applicable
Stereotactic Magnetic Resonance Guided Radiation Therapy
Prostate CancerLung CancerSpine Metastases+10 more
Dana-Farber Cancer Institute397 enrolled2 locationsNCT04115254
Recruiting
Not Applicable
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
MesotheliomaAtelectasisPneumothorax+11 more
Brigham and Women's Hospital230 enrolled1 locationNCT06538376
Recruiting
Phase 1Phase 2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Endometrial CancerAdvanced Solid TumorDiffuse Large B Cell Lymphoma+5 more
Novartis Pharmaceuticals275 enrolled60 locationsNCT04104776